Navigation Links
Hepatitis C Treatment May Hamper Kids' Growth

MONDAY, Aug. 13 (HealthDay News) -- Children with hepatitis C who are treated with peginterferon alpha may experience growth-related side effects from the therapy, a new study reveals.

Although weight changes are reversible, many children's height for their age may be lower even after the treatment for hepatitis C virus (HCV) ends, the researchers found.

The study was published in the August issue of Hepatology.

"While HCV in children is typically mild, some cases do progress to cirrhosis and liver cancer," lead study author Dr. Maureen Jonas, director of the Center for Childhood Liver Disease and medical director of the Liver Transplant Program at Boston Children's Hospital, said in a journal news release.

"Treatment of HCV with peginterferon and ribavirin is approved for young children and offers the most benefit while liver disease is mild. However, there are concerns about the potential side effects of peginterferon therapy in children, which is the focus of our current study," Jonas explained.

The researchers followed 107 children (average age 11) with chronic hepatitis C, who participated in a study on the safety of hepatitis C treatments for an additional two years. Of these children, 55 percent were boys and 82 percent were white. When their treatment began, all of the children were of normal height, weight and body mass index (BMI), a measurement that takes both weight and height into account.

The children were divided into three groups based on how long they were treated with peginterferon: 24, 48 or 72 weeks. The study found that while on the therapy, some of the children had decreases in height, weight, and BMI scores compared to standard scores. Moreover, 33 percent of the children on the therapy for 48 weeks showed even larger decreases in height-for-age scores.

Children who had been treated with peginterferon for 48 or 72 weeks had lower average height scores at the two-year follow-up point than when treatment began. The children's height-for-age scores did not rebound as quickly as their weight and BMI. However, the children's diet and level of physical activity had not changed over the course of the study.

"Additional investigation of growth patterns is needed to determine long-term outcomes so that optimal timing of treatment can be determined for children with chronic HCV," Jonas concluded.

Although the study found an association with peginterferon treatment and changes in children's growth patterns, it did not show a cause-and-effect relationship.

More information

Visit the U.S. Centers for Disease Control and Prevention to learn more about hepatitis C.

-- Mary Elizabeth Dallas

SOURCE: Hepatology, news release, Aug. 9, 2012

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hepatitis A vaccination in children under 2 remains effective for 10 years
2. World Hepatitis Day - EASL calls on the United Nations to join the effort to tackle viral hepatitis
3. Smoking Tied to Risk for Hepatitis Return After Liver Transplant
4. NIH scientists identify likely predictors of hepatitis C severity
5. Herbal remedy used to treat hepatitis C proves ineffective, Penn study finds
6. Adding Vitamin B12 to Standard Drugs Might Help Fight Hepatitis C
7. Hepatitis C may increase deaths from both liver-related and other diseases
8. Milk Thistle of Little Help Against Hepatitis C: Study
9. Helper T cells, not killer T cells, might be responsible for clearing hepatitis A infection
10. Hepatitis C Virus Levels Higher in Certain Injection Drug Users
11. Current and former smokers at risk for recurrent hepatitis post-liver transplantation
Post Your Comments:
Related Image:
Hepatitis C Treatment May Hamper Kids' Growth
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... In an ... Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of ... and surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 ...
(Date:11/25/2015)... ... , ... Today, Mothers Against Drunk Driving (MADD) learned that the ... the first time since 2011. In 2014, there were 9,967 fatalities involving an alcohol ... National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in ...
(Date:11/25/2015)... ... November 25, 2015 , ... In honor of ... Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension (PH) patients ... by the public, will receive special recognition throughout 2016 as part of PHA’s ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract ... significant expansion of its current state of the art research, development and manufacturing ... to increase its manufacturing capacity as well as to support its clients’ growing ...
(Date:11/25/2015)... ... November 25, 2015 , ... Many people know of the common ... cold hands, and dry skin. But many people who find their cholesterol levels and ... instead of their thyroid, especially if they don’t have any of the other symptoms. ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... , Nov. 24, 2015  DILON Diagnostics and ... signed an agreement for DILON to distribute GE,s Discovery ... the globe. The signing of this distribution agreement will provide ... Molecular Breast Imaging system and is considered an initial ... better healthcare solutions for clinicians and their patients. ...
(Date:11/24/2015)... November 24, 2015 ... adds Latest Guidebook for Chinese Medical ... pages published in November 2015 to the medical ... intelligence library at . ... fastest growing global economies with a fifth population ...
Breaking Medicine Technology: